Integral Derivatives’s Tenet Healthcare THC Stock Holding History

Integral Derivatives’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,803	Closed	-$220K	–	1244
2015 Q2	$220K	Buy	+3,803	New	+$194K	0.01%	954

Other funds holding THC

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Integral Derivatives's THC Position: Q3 2015 in Review

Integral Derivatives sold out of Tenet Healthcare (THC) in Q3 2015, closing a stake of 3,803 shares — an estimated $220K sold.

Integral Derivatives first reported a position in THC in Q2 2015 and held it in 1 quarter. The position peaked at $220K in Q2 2015. 311 funds tracked by Wall St. Rank hold THC as of Q3 2015.

Integral Derivatives reported no remaining Tenet Healthcare position as of Q3 2015 after selling out during the quarter.
Integral Derivatives sold 3,803 Tenet Healthcare shares in Q3 2015, an estimated $220K.
Integral Derivatives first reported a position in Tenet Healthcare in Q2 2015 and held it in 1 quarter.
Integral Derivatives's Tenet Healthcare position peaked at $220K in Q2 2015.
311 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2015.

Based on Integral Derivatives's 13F filing for Q3 2015, filed 15 Oct 2015.